Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly



Status:Completed
Conditions:Lung Cancer, Lung Cancer, Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:70 - Any
Updated:9/26/2018
Start Date:June 9, 2014
End Date:July 14, 2017

Use our guide to learn which trials are right for you!

Safety and Efficacy of Nab-paclitaxel (Abraxane) in Combination With Carboplatin as First Line Treatment in Elderly Subjects With Advance Non-Small Cell Lung Cancer (NSCLC): A Phase IV, Randomized, Open-Label, Multicenter Study (Abound.70+)

Study comparing two regimens of nab-paclitaxel and carboplatin combination in elderly
subjects (≥ 70 years old) with advanced NSCLC

This is a Phase IV, randomized, open-label, multicenter study of continuous weekly versus
weekly times three with one-week break nab-paclitaxel in combination with carboplatin as
first-line treatment in elderly subjects (≥ 70 years old) with advanced non small cell lung
cancer who have not received prior chemotherapy for their advanced disease and are not
candidates for curative surgery or radiation therapy. The primary study endpoint is the
percentage of subjects with either peripheral neuropathy or myelosuppression adverse events.
Patients will continue treatment until they develop progressive disease, unacceptable
side-effects or wish to withdraw from the study, according to local standard of care.
Patients will have radiographic evaluations every 6 weeks while on treatment.

Inclusion Criteria: -

- Inclusion Criteria: -

1. Age ≥ 70 years at the time of signing the Informed Consent Form.

2. Understand and voluntarily provide written informed consent prior to the conduct
of any study related assessments/procedures.

3. Able to adhere to the study visit schedule and other protocol requirements.

4. Histologically or cytologically confirmed locally advanced or metastatic non
small cell lung cancer who are not candidates for curative surgery or radiation
therapy.

5. No other current active malignancy requiring anticancer therapy.

6. Radiographically documented measurable disease per RECIST v 1.1

7. No prior chemotherapy for the treatment of metastatic disease. Adjuvant
chemotherapy is permitted providing that cytotoxic chemotherapy was completed 12
months prior to signing the informed consent form (ICF) and without disease
recurrence. Participans with previously known epidermal growth factor receptor
mutation or anaplastic lymphoma kinase gene translocation must have failed or had
intolerance to one treatment with epidermal growth factor receptor tyrosine
kinase inhibitor or anaplastic lymphoma kinase inhibitor therapy, respectively.

8. Absolute neutrophil count ≥ 1500 cells/cubic millimetre.

9. Platelets ≥ 100,000 cells/cubic millimetre.

10. Hemoglobin ≥ 9 grams/decilitre.

11. Aspartate transaminase/serum glutamic oxaloacetic transaminase/ alanine
transaminase/serum glutamic pyruvic transaminase ≤ 2.5 × upper limit of normal
range or ≤ 5.0 × upper limit of normal range if liver metastases.

12. Total bilirubin ≤ 1.5 millilitre/decilitre (unless there is a known history of
Gilberts Syndrome).

13. Creatinine clearance > 40 millilitre/minute calculated using Cockcroft-Gault
equation (if renal impairment is suspected 24 hour urine collection for
measurement is required).

14. Eastern Cooperative Oncology Group performance status 0 or 1.

15. Females who (1) have undergone hysterectomy (the surgical removal of the uterus)
or bilateral oophorectomy (the surgical removal of both ovaries) or (2) have been
naturally postmenopausal for at least 24 consecutive months (ie, has not had
menses at any time during the preceding 24 consecutive months).

16. Male subjects must: Practice true abstinence or agree to use a condom during
sexual contact with a pregnant female or a female of childbearing potential while
participating in the study, during dose interruptions and for 6 months following
study drug discontinuation, even if he has undergone a successful vasectomy.

Exclusion Criteria:

- 1. Evidence of active brain metastases, including leptomeningeal involvement (prior
evidence of brain metastasis are permitted only if treated and stable and off therapy
for ≥ 4 weeks prior to signing Informed consent form. Magnetic Resonance Imaging of
the brain (or Computed Tomography scan w/contrast) is preferred for diagnosis.

2. History of leptomeningeal disease. 3. Only evidence of disease is non measurable.
4. Preexisting peripheral neuropathy of Grade 2, 3, or 4 (per Common Terminology
Criteria for Adverse Events v4.0).

5. Participant has received radiotherapy ≤ 4 weeks or limited field radiation for
palliation ≤ 2 weeks prior to starting investigational product, and/or from whom ≥ 30%
of the bone marrow was irradiated. Prior radiation therapy to a target lesion is
permitted only if there has been clear progression of the lesion since radiation was
completed.

6. Venous thromboembolism within 1 month prior to signing informed consent form.

7. Current congestive heart failure (New York Heart Association Class II-IV). 8.
History of the following within 6 months prior to first administration of a study
drug: a myocardial infarction, severe/unstable angina pectoris,coronary/peripheral
artery bypass graft, New York Heart Association Class III-IV heart failure,
uncontrolled hypertension, clinically significant cardiac dysrhythmia or clinically
significant Electrocardiogram abnormality, cerebrovascular accident, transient
ischemic attack, or seizure disorder.

9. Participant has a known infection with hepatitis B or C, or history of human
immunodeficiency virus infection, or participant is receiving immunosuppressive or
myelosuppressive medications that would in the opinion of the investigator, increase
the risk of serious neutropenic complications.

10. Participant has an active, uncontrolled bacterial, viral, or fungal infection(s)
requiring systemic therapy, defined as ongoing signs/symptoms related to the infection
without improvement despite appropriate antibiotics, antiviral therapy, and/or other
treatment.

11.History of interstitial lung disease, sarcoidosis, silicosis, idiopathic pulmonary
fibrosis, or pulmonary hypersensitivity pneumonitis.

12. Treatment with any investigational product within 28 days prior to signing the
informed consent form.

13. History of allergy or hypersensitivity to nab-paclitaxel or carboplatin. 14.
Currently enrolled in any other clinical protocol or investigational trial that
involves administration of experimental therapy and/or therapeutic devices. 15. Any
other clinically significant medical condition, psychiatric illness, and/or organ
dysfunction that will interfere with the administration of the therapy according to
this protocol or which, in the views of investigator, preclude combination
chemotherapy.

16. Participant has any other malignancy within 5 years prior to randomization.
Exceptions include the following: squamous cell carcinoma of the skin, in-situ
carcinoma of the cervix, uteri, non-melanomatous skin cancer, carcinoma in situ of the
breast, or incidental histological finding of prostate cancer Tumor, Lymph Node,
Metastatic (TNM stage of T1a or T1b). All treatment of which should have been
completed 6 months prior to signing Informed consent form.

17. Any condition including the presence of laboratory abnormalities, which places the
participant at unacceptable risk if he/she were to participate in the study.

18. Any medical condition that confounds the ability to interpret data from the study.

19. Females who (1) have not undergone hysterectomy (the surgical removal of the
uterus) or bilateral oophorectomy (the surgical removal of both ovaries) or (2) have
not been naturally postmenopausal for at least 24 consecutive months (ie, has had
menses at any time during the preceding 24 consecutive months).
We found this trial at
55
sites
Niles, Illinois 60714
?
mi
from
Niles, IL
Click here to add this to my saved trials
3550 Jerome Avenue
Bronx, New York 10467
(718) 920-4321
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
?
mi
from
Bronx, NY
Click here to add this to my saved trials
433 Southwest 10th Street
Ocala, Florida 34471
?
mi
from
Ocala, FL
Click here to add this to my saved trials
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials
220 S Palisade Dr # 204
Santa Maria, California 93454
?
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Amarillo, Texas 79106
?
mi
from
Amarillo, TX
Click here to add this to my saved trials
Bakersfield, California 93309
?
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Baltimore, Maryland 21237
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Boca Raton, Florida 33486
?
mi
from
Boca Raton, FL
Click here to add this to my saved trials
?
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Chapel Hill, North Carolina 27514
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Charlotte, North Carolina 28211
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Cherry Hill, New Jersey 08003
?
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Corvallis, Oregon 97330
?
mi
from
Corvallis, OR
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Denver, Colorado 80218
?
mi
from
Denver, CO
Click here to add this to my saved trials
Detroit, Michigan 48202
?
mi
from
Detroit, MI
Click here to add this to my saved trials
East Brunswick, New Jersey 70072
?
mi
from
East Brunswick, NJ
Click here to add this to my saved trials
?
mi
from
Evanston, IL
Click here to add this to my saved trials
Fullerton, California 92835
?
mi
from
Fullerton, CA
Click here to add this to my saved trials
706 Holiday Drive
Galveston, Texas 77573
?
mi
from
Galveston, TX
Click here to add this to my saved trials
?
mi
from
Gilroy, CA
Click here to add this to my saved trials
2635 North 7th Street
Grand Junction, Colorado 81501
?
mi
from
Grand Junction, CO
Click here to add this to my saved trials
500 University Dr
Hershey, Pennsylvania 17033
(717) 531-6955
Penn State Milton S. Hershey Medical Center Penn State Milton S. Hershey Medical Center, Penn...
?
mi
from
Hershey, PA
Click here to add this to my saved trials
Hot Springs, Arkansas 71913
?
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Indianapolis, Indiana 46237
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Jacksonville, Florida 32207
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Johnson City, New York 13790
?
mi
from
Johnson City, NY
Click here to add this to my saved trials
Lake Success, New York 11042
?
mi
from
Lake Success, NY
Click here to add this to my saved trials
?
mi
from
Lawton, OK
Click here to add this to my saved trials
1 Medical Center Dr
Lebanon, New Hampshire 03756
 (603) 650-5000
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock is a national leader in patient-centered health care and building...
?
mi
from
Lebanon, NH
Click here to add this to my saved trials
94 Old Short Hills Road
Livingston, New Jersey 07039
(973) 322-5000
Saint Barnabas Medical Center As a Barnabas Health facility, Saint Barnabas Medical Center is committed...
?
mi
from
Livingston, NJ
Click here to add this to my saved trials
Longview, Texas 75601
?
mi
from
Longview, TX
Click here to add this to my saved trials
Marrero, Louisiana 70072
?
mi
from
Marrero, LA
Click here to add this to my saved trials
Morristown, New Jersey 07962
?
mi
from
Morristown, NJ
Click here to add this to my saved trials
New Orleans, Louisiana 70121
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
8303 Dodge Street
Omaha, Nebraska 68114
(402) 354–4000
Nebraska Methodist Hospital Methodist Hospital is a general medical and surgical hospital in Omaha, NE....
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Orlando, Florida 32804
?
mi
from
Orlando, FL
Click here to add this to my saved trials
?
mi
from
Oxnard, CA
Click here to add this to my saved trials
225 Medical Center Drive
Paducah, Kentucky 42003
?
mi
from
Paducah, KY
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19107
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19111
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
320 E North Ave
Pittsburgh, Pennsylvania 15212
(412) 359-3131
Allegheny General Hospital At Allegheny General Hospital, our physicians and healthcare staff have earned an...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
405 Hilgard Avenue
Santa Monica, California 90404
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Seattle, Washington 98111
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Somerville, New Jersey 08876
?
mi
from
Somerville, NJ
Click here to add this to my saved trials
?
mi
from
Sparta, NJ
Click here to add this to my saved trials
?
mi
from
Syracuse, NY
Click here to add this to my saved trials
Tucson, Arizona 85712
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
Vancouver, Washington 98684
?
mi
from
Vancouver, WA
Click here to add this to my saved trials
818 N. Emporia, #403
Wichita, Kansas 67214
(316) 262-4467
Cancer Center of Kansas The physicians of Cancer Center are hematologists and oncologists. The staff...
?
mi
from
Wichita, KS
Click here to add this to my saved trials
Winston-Salem, North Carolina 27103
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Worcester, Massachusetts 01608
?
mi
from
Worcester, MA
Click here to add this to my saved trials
Youngstown, Ohio 44501
?
mi
from
Youngstown, OH
Click here to add this to my saved trials